{"id":"W2109157463","doi":"10.2337/diabetes.54.10.2988","title":"Dipeptidyl Peptidase IV Inhibition for the Treatment of Type 2 Diabetes","year":2005,"lang":"en","type":"article","venue":"Diabetes","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":491,"is_retracted":false,"has_abstract":true,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Dipeptidyl peptidase; Incretin; Dipeptidyl peptidase-4; Internal medicine; Dipeptidase; Toxicity; Endocrinology; Tolerability; Type 2 diabetes; Diabetes mellitus; Pharmacology; Medicine; Biology; Enzyme; Adverse effect; Biochemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002171842,0.0005683039,0.0003011249,0.0004075647,0.0001229871,0.0002490299,0.0001979629,0.0002209088,0.001686863],"category_scores_gemma":[0.00008473975,0.000075089,0.0002657018,0.0002447755,0.0001292505,0.0001249019,0.0001847183,0.0009919485,0.0004951495],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003112354,"about_ca_system_score_gemma":0.0002529103,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004795662,"about_ca_topic_score_gemma":0.001519919,"domain_scores_codex":[0.9999027,0.00002159638,0.000007664862,0.00001544705,0.00003378243,0.00001884511],"domain_scores_gemma":[0.9999641,0.000004961379,0.00001255076,0.000001557654,0.000005759731,0.00001109238],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.003416033,0.001256783,0.001221013,0.002310098,0.0001854204,0.0009995817,0.00003978091,0.0006311191,0.5249994,0.00247483,0.01164063,0.4508254],"study_design_scores_gemma":[0.005546531,0.02159758,0.02096259,0.0008159814,0.0007632326,0.008071131,0.00008625829,0.003765499,0.475139,0.001625539,0.4615423,0.00008423882],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.2773114,0.6649132,0.01809442,0.003649662,0.002235788,0.0005295876,0.001292973,0.0004673648,0.0315056],"genre_scores_gemma":[0.683972,0.2792864,0.01517311,0.001685146,0.0005900926,0.0002812731,0.001110287,0.00004804951,0.01785374],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.001686863,"threshold_uncertainty_score":0.005643129,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01898075038402413,"score_gpt":0.2728764479038947,"score_spread":0.2538956975198706,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}